http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89b0587363ddc5274a0ad4573f01ecb4
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Rao |
| name | Anjana Rao |
| given-name | Anjana |
| organization-name | Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 Department of Pathology, Harvard Medical School, and Center for Blood Research, Boston, Massachusetts 02115 Division of Signaling and Gene Expression, La Jolla Institute, La Jolla, CA 92037;; Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, CA 92037;; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037 2Moores Cancer Center, University of California San Diego, La Jolla, California.; 4Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, California. Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA. Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California 92037, United States Center for Blood Research, Boston, Massachusetts 02115 From the Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, MA; and Departamento de Fisiologia e Farmacodinâmica, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil. Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts 02115;, F. Mercurio, H. Zhu, B. W. Murray, B. Bennett, J. Li, D. Young, M. Barbosa, A. Manning, Signal Pharmaceuticals, Inc., 5555 Oberlin Drive, San Diego, CA 92121, USA.; A. Shevchenko and M. Mann, European Molecular Biology Laboratory, Meyerhofstrasse 1, D-69012 Heidelberg, Germany.; A. Rao, Center for Blood Research and the Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA. Department of Pathology, Harvard Medical School, Boston, MA; and; Immune Disease Institute, Boston, MA LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY Department of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92034;; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037;; Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 The CBR Institute for Biomedical Research, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115 1CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, Boston, MA 02115 Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037;; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093;; Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093 Divisions of aSignalling and Gene Expression and; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037; La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA 02115, USA.; IFOM–The FIRC Institute for Molecular Oncology, Milano, Via Adamello 16 Milan 20139, Italy.; Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Max Delbrück Center for Molecular Medicine, Robert-Rössle-Strasse 10, D-13125 Berlin, Germany. La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;; Immune Disease Institute, Harvard Medical School and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115;; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92037;; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037 Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115; Department of Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; and Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA, 2Department of Statistics, Northwestern University, Evanston, IL 60208, USA, 3Division of Signaling and Gene Expression, The La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA and 4Program in Cellular and Molecular Medicine, Children’s Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA, 2Department of Statistics, Northwestern University, Evanston, IL 60208, USA, 3Division of Signaling and Gene Expression, The La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA and 4Program in Cellular and Molecular Medicine, Children’s Hospital and Harvard Medical School, Boston, MA 02115, USA La Jolla Institute of Allergy and Immunology, San Diego, CA; Department of Pathology and Immune Disease Institute, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115 Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA Divisions of aSignaling and Gene Expression and; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037; and; Department of Pharmacology and; Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093 Harvard Medical School, CBR Institute for Biomedical Research, Boston, Massachusetts 02115;, Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; Departments of Biological Chemistry and Molecular Pharmacology and Pathology, Harvard Medical School, Boston, MA 02115; Ph.D. Program in Biological and Biomedical Sciences, Division of Medical Sciences, Faculty of Arts and Sciences, Harvard University, Boston, MA 02115; Center for Blood Research, 200 Longwood Avenue, Boston, MA 02115; and Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain Department of Pathology, Harvard Medical School and Center for Blood Research, Institute for Biomedical Research, 200 Longwood Avenue, Boston MA 02115; Departments of Molecular Biology, Pathology, Internal Medicine (Nephrology), and Pediatrics, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-9148; and Department of Pathology, Tufts University School of Veterinary Medicine, North Grafton, MA 01536 Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, USA; La Jolla Institute for Allergy and Immunology, La Jolla, California, USA 1The CBR Institute for Biomedical Research and Department of Pathology, Department of Cancer Biology, Harvard Medical School, Boston, MA 02115 Department of Pathology, Harvard Medical School and Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital, Boston, MA 02115; La Jolla Institute for Immunology, La Jolla, California, USA;, ,; Sanford Consortium for Regenerative Medicine, La Jolla, California, USA; Moores Cancer Center, UC San Diego, La Jolla, California, USA; Program in Immunology, UC San Diego, La Jolla, California, USA; Department of Pharmacology, UC San Diego, La Jolla, California, USA From the Department of Pathology, Harvard Medical School, and The Center for Blood Research, Boston, MA; the Department of Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology; and the Max-Planck-Institute for Infection Biology, Berlin, Germany. La Jolla Institute for Allergy & Immunology, La Jolla, California 92307, United States Division of Signaling and Gene Expression, San Diego, United States; Sanford Consortium for Regenerative Medicine, San Diego, United States; Department of Pharmacology, University of California, San Diego, San Diego, United States; Moores Cancer Center, University of California, San Diego, San Diego, United States From the Department of Pathology, Harvard Medical School, and the Center for Blood Research, Boston, Massachusetts 02115 La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA; Department of Pharmacology and Moores Cancer Center, University of California, La Jolla, CA 92037, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School , Boston, Massachusetts Division of Signalling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;; Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92037;; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037 Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;; Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA 02115; and Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037 3; Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093 4; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 5 Sanford Consortium for Regenerative Medicine and La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 50077 7 Signaling and Gene Expression Division, La Jolla Institute for Allergy and Immunology, San Diego, CA 92037; and Department of Pathology, Harvard Medical School and Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115;; Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92037; and; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037 Harvard Medical School and the Immune Disease Institute, Boston, MA 02115 1 Immune Disease Institute and the Department of Pathology, Harvard Medical School, Boston, MA 02115 2 Division of Signaling and Gene Expression, La Jolla Institute, San Diego, CA, USA.; Sanford Consortium for Regenerative Medicine, San Diego, CA, USA.; Department of Pharmacology, University of California, San Diego, San Diego, CA, USA.; Moores Cancer Center, University of California, San Diego, San Diego, CA, USA. La Jolla Institute for Allergy and Immunology, La Jolla, United States Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;; Department of Pharmacology and; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 Division of Signaling and Gene Expression La Jolla Institute for Allergy and Immunology La Jolla CA USA; Department of Pharmacology and Moores Cancer Center University of California at San Diego La Jolla CA USA; Sanford Consortium for Regenerative Medicine La Jolla CA USA *Center for Blood Research, Harvard Medical School, Boston, MA 02115; Center for Blood Research and the *Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115; †Immune Disease Institute and Harvard Medical School, Boston, MA 02115; and Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, CA 92037;; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093;; Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093;; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037 Division of Signaling and Gene Expression, La Jolla Institute , San Diego, California, USA; Sanford Consortium for Regenerative Medicine , La Jolla, California, USA; Department of Pharmacology and Moores Cancer Center, University of California , San Diego, La Jolla, California, USA S. Kim and A. Rao are in the Department of Pathology, Harvard Medical School, and the CBR Institute for Biomedical Research, 200 Longwood Avenue, Boston, MA 02115, USA. Department of Pathology, Harvard Medical School and Immune Disease Institute, 200 Longwood Avenue, Boston, MA 02115, USA. Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Harvard Medical School, Boston, Massachusetts Department of Pathology, Harvard Medical School;; The Center for Blood Research, 200 Longwood Avenue, Boston, MA 02115, USA. Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 Department of Pathology, Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA.; Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142, USA. *CBR Institute for Biomedical Research, Harvard University, Boston, MA 02115; and La Jolla Institute and Department of Pharmacology, University of California, San Diego, La Jolla, CA; The Center for Blood Research; Harvard Medical School, USA Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Pathology, Harvard Medical School, and CBR Institute for Biomedical Research, 200 Longwood Avenue, Boston, MA 02115, USA. Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115 Division of Tumor Virology, Dana-Farber Cancer Institute, Boston, MA 02115 and Department of Pathology, Harvard Medical School, Boston, MA 02115. 5Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California. Department of Pathology, Harvard Medical School and Immune Disease Institute, Boston, MA 02115, USA. CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. La Jolla Institute for Allergy and Immunology and Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA. Department of Pathology, Harvard Medical School, The Center for Blood Research, Boston, MA 02115 La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; and ‡Department of Pathology, Harvard Medical School and Immune Disease Institute, Boston, MA 02115 Department of Pathology, Harvard Medical School, and the CBR Institute for Biomedical Research, 200 Longwood Avenue, Boston, MA 02115; and Graduate Program in Immunology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115 Division of Immunology, Children's Hospital, CBR Institute for Biomedical Research, and Departments of Pediatrics and Pathology, Harvard Medical School, Boston, MA 02115 The author is at the Center for Blood Research and the Department of Pathology, Harvard Medical School, Warren Alpert Building, 200 Longwood Avenue, Boston, MA 02115, USA. Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, 200 Longwood Avenue, Boston, MA 02115; and; Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115 Department of Pathology, Harvard Medical School and the Immune Disease Institute, Boston, MA 02115 |
Incoming Links
Total number of triples: 351.